A new poll of Americans finds that people who are currently on Schedule 2 of the federal drug law are much less likely to report a positive drug test than those who are not on that drug.
In a survey by Quinnipiac University, 51 percent of respondents who were currently on the drug, while just 28 percent of those who were not were.
The study, published in the journal Drug and Alcohol Dependence, found that those who said they were currently off Schedule 2 were more likely to have experienced an adverse test result.
People who are current on Schedule 3 of the law, which has a higher potential for abuse, were more than twice as likely to say they had experienced an unfavorable test result, the poll found.
The poll was conducted online from Jan. 20 to Jan. 26.
It has a margin of error of plus or minus 4 percentage points.
“There are many reasons for why people take this drug and some people choose it, but it’s not the most rational way to handle your problems,” said Dr. Steven Katz, a professor of psychiatry at the University of Chicago Medical School.
According to the U.S. Centers for Disease Control and Prevention, there are about 10,000 people currently on these two drugs and there are more than 40,000 in treatment.
There is a significant increase in usage over the past few years.
The CDC reported last week that the rate of new drug use for marijuana has increased more than threefold since 2014.
A study published in November found that people taking THC were more susceptible to the effects of the drug’s psychoactive effects.
In the study, researchers surveyed people who had used marijuana, and found that while a significant percentage had experienced the drug with a positive test, they also had an increased risk of developing psychosis, anxiety, depression and other mental health problems.
In March, the Trump administration released guidelines for treating marijuana-related anxiety.
The new guidelines recommended the use of CBT, which uses a combination of cognitive behavioral therapy and psychoeducational techniques, and CBT-lite, which focuses on the patient’s own symptoms rather than the therapist’s or doctor’s diagnosis.
More from The Hill:Trump signs bill to delay opioid addiction treatment for six monthsTrump signs Senate bill to end opioid addiction coverage for 6 monthsDemocrats, meanwhile, have been fighting to repeal the opioid addiction and death penalty.
House Democrats are expected to take up a bill next week that would eliminate the death penalty for anyone who has a prior conviction on drug-related charges, a move that would also prevent states from enacting new death sentences.